NCT04297618View on ClinicalTrials.gov

The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers

PHASE4CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

April 18, 2024

Study Completion Date

April 18, 2024

Conditions

Dry Eye

Interventions

DRUG

Xiidra

Xiidra (lifitegrast 5% ophthalmic solution)

Trial Locations (1)

N2L 3G1

Centre for Ocular Research & Education, Waterloo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

University of Waterloo

OTHER